Patent number: 8603023
Abstract: Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems, and ingestible pills. In one embodiment, the implantable system comprises a device delivering a therapeutic substance to a target location within the gastrointestinal tract of a patient in order to initiate an intestinal braking effect which would promote sensations of satiety and stimulate excess weight loss for the patient.
Type:
Grant
Filed:
May 11, 2011
Date of Patent:
December 10, 2013
Assignee:
Ethicon Endo-Surgery, Inc.
Inventors:
Thomas E. Albrecht, Jeffrey L. Aldridge, Sean P. Conlon, Michael S. Cropper, Denzel Z. Herrera-Davis, Daniel F. Dlugos, Jr., Jason L. Harris, Christopher J. Hess, Thomas W. Huitema, John V. Hunt, Prasanna Malaviya, Mark S. Ortiz, Mark D. Overmyer, Alessandro Pastorelli, Galen C. Robertson, Frederick E. Shelton, IV, Michael J. Stokes, Foster B. Stulen, James W. Voegele, William B. Weisenburgh, II, Christopher W. Widenhouse, Tamara S. Vetro Widenhouse, James A. Woodard, Jr., David C. Yates, Mark S. Zeiner, Andrew M. Zwolinski